ReviewImmunity, inflammation and disease2022
Oral and intranasal vaccines against SARS-CoV-2: Current progress, prospects, advantages, and challenges.
Sanchita Kar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this papercites it